Does inflammation raise ferritin and cause low transferrin saturation despite normal serum iron?

Ferritin is an established acute-phase reactant, and its measurement is a critical component of assessing iron status in the context of inflammation. Because inflammation can artificially elevate ferritin levels, clinical interpretation requires distinguishing between absolute iron deficiency and functional iron sequestration.

Clinical evidence and mechanisms

• Ferritin as an acute-phase reactant: Serum ferritin concentrations rise significantly during inflammatory states, independent of actual body iron stores. This elevation is triggered by pro-inflammatory cytokines, specifically Interleukin-1 (IL-1), Interleukin-6 (IL-6), and Tumor Necrosis Factor-alpha (TNF-α), which enhance ferritin mRNA translation. Because of this, a "normal" ferritin level in an inflammatory state can mask a true underlying iron deficiency.
• Iron sequestration and the Hepcidin axis: Inflammation initiates the cellular iron sequestration response (CISR). The primary driver is IL-6, which stimulates the liver to produce hepcidin. Hepcidin then binds to ferroportin—the only known cellular iron exporter—on the surface of macrophages and enterocytes, leading to its degradation. This mechanism effectively traps iron within these cells, preventing it from entering the bloodstream for use in red blood cell production.
• Impact on iron markers: The sequestration of iron typically leads to low transferrin saturation (TSAT), often defined as <20% in inflammatory conditions. While this process generally results in low serum iron (hypoferremia), TSAT can drop while serum iron remains within a borderline normal range during early or fluctuating phases of chronic disease. This occurs because the body redistributes iron pools and increases ferritin synthesis as part of the acute-phase response, leading to "functional" iron deficiency where iron is present in the body but unavailable for physiological use.

Bottom line

Ferritin levels consistently rise during inflammation due to cytokine-driven synthesis, necessitating the use of higher diagnostic thresholds or concurrent C-reactive protein (CRP) testing. Inflammation further limits iron availability by sequestering it within cells via the IL-6/hepcidin/ferroportin pathway, which manifests as low transferrin saturation even if serum iron or ferritin levels appear adequate.